Kirsty Duncan’s motion calling for an investigation of CIHR’s handling of the development of an MS registry and clinical trials for CCSVI will start off the Fall session of the House with a CCSVI bang.

http://www.facebook.com/notes/ccsvi-ontario/kirsty-duncan-continues-the-ccsvi-battle-in-the-house/384147031656207

M-403 — September 13, 2012 — Ms. Duncan (Etobicoke North) — That, in the opinion of the House: (a) the government should recognize that (i)between 55,000 and 75,000 Canadians live with devastating multiple sclerosis, and 400 Canadians die each year of the disease, (ii) 30,000 individuals have been treated for chronic cerebrospinal venous insufficiency (CCSVI) in 60 countries,(iii) there is a preponderance of positive CCSVI studies using multi-modal imaging to determine diagnosis, (iv) there have been three major safety studies of the CCSVI procedure involving over 1,000 patients, (v) phase ll and lll clinical trials are already underway in other countries, (vi) while a MS monitoring system and clinical trials were promised in March 2011 and June 2011respectively, neither has yet to begin (vii) considerable weaknesses were exposed by Anne Kingston’s article in Macleans, entitled “The Silent Treatment”, concerning the handling of CCSVI; and (b) the Standing Committee on Health should investigate the Canadian Institutes of Health Research's handling of the development of a registry and clinical trials for CCSVI.

This is the link for the motion:  http://www.parl.gc.ca/HousePublications/Publication.aspx?Pub=NoticeOrder&Mode=1&Language=E&Parl=41&Ses=1&File=11